These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4334084)

  • 61. Combination therapy with vincristine sulfate (NSC-67574) and cyclophosphamide (NSC-26271) for generalized malignant schwannoma--a case report.
    Valdes OS; Maurer HM
    Cancer Chemother Rep; 1970 Feb; 54(1):65-8. PubMed ID: 5527013
    [No Abstract]   [Full Text] [Related]  

  • 62. [Results of treatment of solid tumors with massive levels of methotrexate and folinic acid combination. Apropos of 49 cases].
    Cheix-Servonnat F; Auboyer C; Bonnafous N; Pommatau E
    Sem Hop; 1973 Jan; 49(2):143-8. PubMed ID: 4346725
    [No Abstract]   [Full Text] [Related]  

  • 63. The private practice of medical oncology: an analysis.
    Mosher MB; Taub RJ; Avedon M
    Cancer Chemother Rep; 1974; 58(6):759-67. PubMed ID: 4447921
    [No Abstract]   [Full Text] [Related]  

  • 64. Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
    Cole MP; Todd ID; Wilkinson PM
    Br J Cancer; 1973 May; 27(5):396-9. PubMed ID: 4576562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 66. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anticancer therapy with hydrea: comparative study of daily vs. intermittent oral dosage.
    Ariel IM
    J Surg Oncol; 1974; 6(1):73-8. PubMed ID: 4819359
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
    Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G
    J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclophosphamide in solid tumors.
    Carter SK; Livingston RB
    Cancer Treat Rev; 1975 Dec; 2(4):295-322. PubMed ID: 766966
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of pulmonary metastasis in breast neoplasms using endoxan].
    Rittmeyer K; Pöhls PH; Gregl A
    Strahlentherapie; 1969 Jun; 137(6):663-9. PubMed ID: 5355161
    [No Abstract]   [Full Text] [Related]  

  • 72. Shnider BI, Salvin LG, Schneiderman MA, Colsky J, Owens AH Jr,+OWENS AH JR, Krant MJ, Miller SP, Frei E 3d,+FREI E III, Hall TC, Spurr CL, McIntyre OR,+MACINTYRE OR, Hoogstraten B, Holland JF: The use of mechlorethamine, cyclophosphamide, and uracil mustard in neoplastic disease: a cooperative study.
    Gold GL
    J Clin Pharmacol J New Drugs; 1970; 10(2):110-20. PubMed ID: 4906539
    [No Abstract]   [Full Text] [Related]  

  • 73. Comparison of methotrexate (NSC-740) and testosterone propionate (NSC-9166) in the treatment of breast cancer.
    Nevinny HB; Hall TC; Haines C; Krant MJ
    J Clin Pharmacol J New Drugs; 1968; 8(2):126-9. PubMed ID: 5240363
    [No Abstract]   [Full Text] [Related]  

  • 74. [Proceedings: Triple-drug massive therapy in advanced ovarian carcinoma].
    Vahrson H
    Arch Gynakol; 1973 Sep; 214(1):391-4. PubMed ID: 4801493
    [No Abstract]   [Full Text] [Related]  

  • 75. [Pulmonary metastases in cancer of the cervix uteri. Some cases treated with chemotherapeutic agents].
    Papavasiliou C; Nicolaidis C
    Gynecol Obstet (Paris); 1970; 69(2):187-93. PubMed ID: 5446034
    [No Abstract]   [Full Text] [Related]  

  • 76. Combined parenteral hyperalimentation and chemotherapy in the treatment of disseminated solid tumors.
    Schwartz GF; Green HL; Bendon ML; Graham WP; Blakemore WS
    Am J Surg; 1971 Feb; 121(2):169-73. PubMed ID: 4993223
    [No Abstract]   [Full Text] [Related]  

  • 77. Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?
    Kearsley JH
    Br Med J (Clin Res Ed); 1986 Oct; 293(6551):871-6. PubMed ID: 3094691
    [No Abstract]   [Full Text] [Related]  

  • 78. Phase I study of L-asparaginase (NSC 109229).
    Wilson WL; Weiss AJ; Ramirez G
    Oncology; 1975; 32(3-4):109-17. PubMed ID: 768851
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation of cyclophosphamide in man and animals.
    Brock N; Gross R; Hohorst HJ; Klein HO; Schneider B
    Cancer; 1971 Jun; 27(6):1512-29. PubMed ID: 5088222
    [No Abstract]   [Full Text] [Related]  

  • 80. Achievement of long duration methotrexate exposure with concurrent low dose thymidine protection: influence of methotrexate pharmacokinetics.
    Howell SB; Tamerius RK
    Eur J Cancer (1965); 1980 Nov; 16(11):1427-32. PubMed ID: 7227419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.